MARINUS PHARMACEUTICALS, INCMARINUS PHARMACEUTICALS, INCMARINUS PHARMACEUTICALS, INC

MARINUS PHARMACEUTICALS, INC

No trades
See on Supercharts

Price target

30.110.000.00%
The 6 analysts offering 1 year price forecasts for MRNS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to MRNS in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MRNS EPS for the last quarter is −8.28 MXN despite the estimation of −8.06 MXN. In the next quarter EPS is expected to reach −5.99 MXN. Track more of MARINUS PHARMACEUTICALS, INC financials and stay on top of what is up with the company.
In the next quarter MARINUS PHARMACEUTICALS, INC revenue is expected to reach ‪228.89 M‬ MXN. Check out MARINUS PHARMACEUTICALS, INC revenue and earnings and make informed decisions.
According to analysts, MRNS price target is 30.11 MXN with a max estimate of 61.60 MXN and a min estimate of 6.16 MXN. Check if this forecast comes true in a year, meanwhile watch MARINUS PHARMACEUTICALS, INC stock price chart and keep track of the current situation with MRNS news and stock market news.
We've gathered opinions of 9 analysts rating MRNS stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.